Title : Immunotherapeutic suppression of indoleamine 2,3-dioxygenase and tumor growth with ethyl pyruvate.

Pub. Date : 2010 Mar 1

PMID : 20160032






6 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Immunotherapeutic suppression of indoleamine 2,3-dioxygenase and tumor growth with ethyl pyruvate. ethyl pyruvate indoleamine 2,3-dioxygenase 1 Homo sapiens
2 In this report, we offer preclinical evidence that the low-cost, anti-inflammatory agent ethyl pyruvate elicits a potent immune-based antitumor response through inhibition of indoleamine 2,3-dioxygenase (IDO), a key tolerogenic enzyme for many human tumors. ethyl pyruvate indoleamine 2,3-dioxygenase 1 Homo sapiens
3 In this report, we offer preclinical evidence that the low-cost, anti-inflammatory agent ethyl pyruvate elicits a potent immune-based antitumor response through inhibition of indoleamine 2,3-dioxygenase (IDO), a key tolerogenic enzyme for many human tumors. ethyl pyruvate indoleamine 2,3-dioxygenase 1 Homo sapiens
4 Consistent with its reported ability to interfere with NF-kappaB function, ethyl pyruvate blocks IDO induction both in vitro and in vivo. ethyl pyruvate indoleamine 2,3-dioxygenase 1 Homo sapiens
5 Our findings that IDO is effectively blocked by ethyl pyruvate treatment deepen emerging links between IDO and inflammatory processes. ethyl pyruvate indoleamine 2,3-dioxygenase 1 Homo sapiens
6 Our findings that IDO is effectively blocked by ethyl pyruvate treatment deepen emerging links between IDO and inflammatory processes. ethyl pyruvate indoleamine 2,3-dioxygenase 1 Homo sapiens